... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prolactinoma Epidemiology...

...Wai Meng Tai; Sze Huey Tan; Damien Meng Yew Tan; Kelvin Siu Hoong Loke; David Chee Eng Ng; Sean Xuexian Yan; Jacqueline Siok Gek Hwang; Kiat Hon Lim; Lih Ming Loh; Peng Chin Kek; Brian Kim Poh Goh; Ser Yee Lee; Alexander Yaw Fui Chung; Simon Yew Kuang Ong Background: Epidemiological evidence...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Adenocarcinoma Epidemiology...

...Raziye Boyar Cetinkaya; Bjarte Aagnes; Espen Thiis-Evensen; Steinar Tretli; Deidi S. Bergestuen; Svein Hansen Background: Epidemiological studies show an increasing trend in the incidence of neuroendocrine neoplasms (NENs). A significant number of NENs occur in less common primary sites...

...Isabel Huguet; Ashley B. Grossman; Dermot O'Toole Background: The reviewing and assessment of epidemiological characteristics of neuroendocrine tumours (NETs) remains a challenge. Despite the fact that it is an uncommon family of neoplasms, several worldwide series have revealed an increasing...

... Neuroendocrine tumor Sporadic pancreatic neuroendocrine tumor Epidemiology Meta-analysis Risk factor Gastroenteropancreatic neuroendocrine tumors (NETs) make up over half of all NETs and are their most common subgroup. Approximately 4-7% of gastroenteropancreatic NETs originate in the pancreas...

..., instructions or products referred to in the content or advertisements. Neuro-endocrine tumour Epidemiology Classification Diagnosis Somatostatin receptor scintigraphy Helical computer tomography PET Non-functioning neuro-endocrine gastro-enteropancreatic tumours are defined...

... since 1992, when treatment with octreotide became largely available in the Netherlands. Neuroendocrine tumours Epidemiology There are also data on second primaries from Sweden [ 14 ]. The more or less synchronous tumours (<1 year) are increased with a relative risk of 15. These are mostly...